T2 Biosystems Stock Price To Book
TTOODelisted Stock | USD 0.18 0.05 21.74% |
T2 Biosystems fundamentals help investors to digest information that contributes to T2 Biosystems' financial success or failures. It also enables traders to predict the movement of TTOO Pink Sheet. The fundamental analysis module provides a way to measure T2 Biosystems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to T2 Biosystems pink sheet.
TTOO |
T2 Biosystems Company Price To Book Analysis
T2 Biosystems' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current T2 Biosystems Price To Book | 14.50 X |
Most of T2 Biosystems' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, T2 Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, T2 Biosystems has a Price To Book of 14.5044 times. This is 43.52% lower than that of the Biotechnology sector and 90.85% higher than that of the Health Care industry. The price to book for all United States stocks is 52.52% lower than that of the firm.
TTOO Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses T2 Biosystems' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of T2 Biosystems could also be used in its relative valuation, which is a method of valuing T2 Biosystems by comparing valuation metrics of similar companies.T2 Biosystems is currently under evaluation in price to book category among its peers.
TTOO Fundamentals
Return On Equity | -6.22 | ||||
Return On Asset | -0.9 | ||||
Operating Margin | (4.91) % | ||||
Current Valuation | 21.91 M | ||||
Shares Outstanding | 21.04 M | ||||
Shares Owned By Insiders | 10.17 % | ||||
Shares Owned By Institutions | 73.51 % | ||||
Number Of Shares Shorted | 826.91 K | ||||
Price To Earning | (2.04) X | ||||
Price To Book | 14.50 X | ||||
Price To Sales | 0.69 X | ||||
Revenue | 7.19 M | ||||
Gross Profit | (24.77 M) | ||||
EBITDA | (43.88 M) | ||||
Net Income | (50.08 M) | ||||
Cash And Equivalents | 13.21 M | ||||
Cash Per Share | 1.87 X | ||||
Total Debt | 49.5 M | ||||
Debt To Equity | 6.64 % | ||||
Current Ratio | 1.87 X | ||||
Book Value Per Share | (6.91) X | ||||
Cash Flow From Operations | (48.14 M) | ||||
Short Ratio | 1.26 X | ||||
Earnings Per Share | (0.03) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 113 | ||||
Beta | 0.38 | ||||
Market Capitalization | 10.48 M | ||||
Total Asset | 34.8 M | ||||
Retained Earnings | (584.3 M) | ||||
Working Capital | (30.96 M) | ||||
Current Asset | 77.78 M | ||||
Current Liabilities | 18.54 M | ||||
Net Asset | 34.8 M |
About T2 Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze T2 Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T2 Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T2 Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |